Iron chelator daphnetin against Pneumocystis carinii in vitro

Chinese Medical Journal

Volumn 117, Issue 11, 2004, Pages 1704-1708

  Ye, Bin ^a   Zheng, Yu Qiang ^a   Wu, Wei Hua ^a   Zhang, Jing ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Daphnetin; Pneumocystis carinii; Ultrastructures

Indexed keywords

CARBON DIOXIDE; CYSTEINE; DAPHNETIN; FERROUS SULFATE; GLUTAMINE; IRON CHELATING AGENT; MAGNESIUM SULFATE; MERCAPTOETHANOL; N ACETYLGLUCOSAMINE; OXYGEN; PUTRESCINE; S ADENOSYLMETHIONINE;

ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; CULTURE MEDIUM; DOSE RESPONSE; GROWTH INHIBITION; IMMUNE DEFICIENCY; IN VITRO STUDY; IRON CHELATION; LUNG; MICROMORPHOLOGY; NONHUMAN; PH MEASUREMENT; PNEUMOCYSTIS CARINII; RAT; TEMPERATURE MEASUREMENT; TRANSMISSION ELECTRON MICROSCOPY; TROPHOZOITE; ULTRASTRUCTURE;

IRON; IRON CHELATING AGENTS; MICROSCOPY, ELECTRON; PNEUMOCYSTIS CARINII; UMBELLIFERONES;

EID: 10244240595     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Merali S, Frevert U, Williams JH, et al. Continuous axenic cultivation of Pneumocystis carinii. Proc Natl Acad Sci U S A 1999;96:2402-2407.
2. Wilkin A, Feinberg J. Pneumocystis carinii pneumonia: a clinical review. Am Fam Physican 1999;60:1699-1708.
3. Hershko C. Control of disease by selective iron depletion: a novel therapeutic strategy utilizing iron ehelators. Bailliere's Clin Haematol 1994;7:965-1000.
4. Weinberg GA. Iron chelators as therapeutic agents against Pneumocystis carinii. Antimicrob Agents Chemocher 1994; 38:997-1003.
5. Clarkson AB Jr, Turkel-Parrella D, Williams JH, et al. Action of deferoxamine against Pneumocystis carinii. Antimicrob Agents Chemother 2001;12:3560-3565.
6. Bartlett MS, Fishman JA, Duekin MM, et al. A new rat model of Pneumocystis carinii infection. J Clin Mierobiol 1988;26:1100-1102.
7. Chin K, Merali S, Shaww MM, et al. Subpopulations Pneumocystis carinii separated by a percoll gradient. J Eukaryotic Microbiol 1996;43:53S.
8. Weiberg ED. Iron and infection. Microbiol Rev 1978;42:45-66.
9. Weiberg ED. Iron withholding: a defense against infection and neoplasia. Physiol Rev 1984;64:65-102.
10. Clarkson, AB, Saric M, Grady RW. Deferoxamine and eflornithine (DL-α-difluoromethylornithine) in a rat model of Pneumocystis carinii pneumonia. Antimicrob Agents Chemother 1990;34:1833-1835.